Marc Forth is the founder of AEON Biopharma. AEON Biopharma has raised $20M in total funding. Latest round: Series A. Backed by Daewoong Pharmaceutical.
Marc Forth serves as a Board Member at AEON Biopharma, a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex. Prior to AEON Biopharma, he was the Senior Vice President of Allergan PLC and Division Head for the U.S. Neurosciences, Urology and Medical Dermatology Division, where he was responsible for the commercialization of products including Botox® for therapeutic uses. He also held various Sales and Marketing roles at TAP Pharmaceutical Inc., a specialty company. Forth holds a B.S. in Business Administration from California State University, Fresno and a Graduate Marketing Certification from Southern Methodist University.
Full founder directory · Investor directory · Company funding database · Fundraising library